CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Er Therapeutics Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Er Therapeutics Inc
1200 Dupont St Ste 23
Phone: (360) 255-3436p:360 255-3436 BELLINGHAM, WA  98225-3100  United States Ticker: PNGMPNGM
This company ceased filing statements with the SEC on 5/31/2012.
Business Summary
Er Therapeutics, Inc., formerly Pengram Corporation (Pengram), is an exploration stage company. The Company has not realized any revenues from its planned operations. The Company is engaged in acquiring exploration and development of natural resource properties. The Company has not commenced business operations. The Company has interests in Clisbako claims and Eureka claims. The Company has 100% interest in a group of ten mineral claims, collectively known as the Clisbako claims, which are located in the Cariboo Mining Division of British Columbia, Canada. The Company also has 100% interest in a series of mineral claims referred to as the CPG Project, Fish Claims and The Golden Snow Property, collectively known as the Eureka claims, which are situated in the Eureka County, Esmeralda County and Mineral County, Nevada.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
8/31/201211/30/2010YesYes---

Industries
SIC Code Description
1000 Metal mining
1041 Gold ores

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, Director Richard W.Donaldson 72 5/2/2008 5/2/2008
Director HowardMetzler 4/21/2011 4/21/2011

Business Names
Business Name
Clisbako Minerals Inc.
Magellan Acquisition Corp.
PNGM

General Information
Outstanding Shares: 58,264,344 (As of 8/31/2012)
Shareholders: 28
Stock Exchange: OTC
Federal Tax Id: 680643436


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, August 29, 2023